EMA Panel Recommends Approval for Eli Lilly's Foundayo, Boosting LLY Stock Outlook

· gurufocus.com

On October 16, 2026, the European Medicines Agency's expert panel recommended approval for six new drugs and five label expansions, including Eli Lilly and Co's

On October 16, 2026, the European Medicines Agency’s expert panel recommended approval for six new drugs and five label expansions, including Eli Lilly and Co...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI